Hybrid polar inducers of transformed cell differentiation/apoptosis. From the cell to the clinic Journal Article


Authors: Marks, P. A.; Richon, V. M.; Breslow, R.; Rifkind, R. A.
Article Title: Hybrid polar inducers of transformed cell differentiation/apoptosis. From the cell to the clinic
Keywords: clinical article; controlled study; protein expression; protein phosphorylation; acute granulocytic leukemia; human cell; clinical trial; drug activity; doxorubicin; nonhuman; pathophysiology; drug megadose; animal cell; mouse; phenotype; animals; mice; cell cycle; protein bcl 2; apoptosis; controlled clinical trial; phase 2 clinical trial; gene expression; thrombocytopenia; cell line; cell differentiation; myelodysplastic syndrome; genetic transfection; cell culture; transcription factor e2f; cell line, transformed; cell polarity; cycline; protein p130; histone deacetylase; trichostatin a; wart virus; cinnamic acid derivative; solubility; histone h4; chemoprevention; methylnitrosourea; hydroxamic acid derivative; leukemia, erythroblastic, acute; myeloma cell; hybrid cell; hexamethylenebisacetamide; acetamides; human; article; virus cell transformation; apolipoprotein e7
Journal Title: Comptes Rendus de l'Academie des Sciences - Serie 3
Volume: 322
Issue: 2-3
ISSN: 0764-4469
Publisher: Elsevier Masson  
Date Published: 1999-02-01
Start Page: 161
End Page: 165
Language: English
DOI: 10.1016/s0764-4469(99)80039-0
PUBMED: 10196668
PROVIDER: scopus
DOI/URL:
Notes: Article -- "Inducteurs de la différenciation des cellules transformées/apoptose. De la cellule à la clinique" -- Export Date: 16 August 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Victoria M Richon
    91 Richon
  2. Paul Marks
    186 Marks
  3. Richard Rifkind
    118 Rifkind